Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cyclic chalcone analogue,
E-2
-(4'-methoxybenzylidene)-1-benzosuberone (MBB), was found to show outstanding in vitro antineoplastic activity against P388, L1210, Molt 4/C8 and CEM cells as well as against a panel of human tumor cell lines. In order to determine whether this promising antineoplastic activity would extend to anticarcinogenic properties, the effects of MBB on the 7,12-dimethylbenz[alpha] anthracene (DMBA)-induced expression of c-myc, Ha-ras and
p53
genes in isolated RNA from liver, lung, kidney, spleen, thymus, lymph nodes and bone marrow of CBA/Ca inbred mice was investigated. DMBA is a well-known chemical carcinogen, which can act as an initiator by causing point mutations in certain oncogenes and tumor suppressor genes. Elevated expression of oncogenes after treatment with DMBA and other carcinogenic chemicals has been noted previously. Administration of MBB simultaneously with DMBA, 24 hours prior to or 24 hours after the DMBA treatment characteristically modified the DMBA-induced expression of the three genes in the 24-hour experiments. The most pronounced suppression effect of MBB could be observed in almost all the investigated tissues when it was administered simultaneously with DMBA. These "short-term" in vivo results support our previous conclusion that MBB can serve as a model molecule for subsequent structural modifications in searching for new effective anticarcinogenic agents.
...
PMID:Effect of E-2-(4'-methoxybenzylidene)-1-benzosuberone on the 7,12-dimethylbenz[alpha]anthracene-induced onco/suppressor gene action in vivo. I: A 24-hour experiment. 1076 99
The cyclic chalcone analogue,
E-2
-(4'-methoxybenzylidene)-1-benzosuberone (MBB), has been found to show outstanding in vitro cytotoxic activity against P388, L1210, Molt 4/C8 and CEM cells, as well as against a panel of human cell lines. In order to determine whether this promising antineoplastic activity would extend to anticarcinogenic properties, the effect of MBB on the 7,12-dimethylbenz [alpha]anthracene (DMBA)-induced expression of the c-myc, Ha-ras and
p53
genes in isolated RNA from the liver, lung, kidney, spleen, thymus, lymph nodes and bone marrow of CBA/Ca inbred mice was investigated. Earlier we had found that administration of MBB can reduce the DMBA-induced 24-hour gene expressions most effectively when it is administered prior to, or simultaneously with, the DMBA-treatment to female CBA/Ca inbred mice. As a continuation of this study, we investigated the effect of MBB on the DMBA-induced gene expressions according to the two protocols in a 48-hour experiment. The 48-hour experiment with female and male CBA/Ca inbred mice also determined the compound which effectively reduced the DMBA-induced c-myc and Ha-ras overexpressions in almost all tissues. While the DMBA-induced gene expressions showed very different patterns, the effectiveness of the two different administrations of MBB was found to be very similar in the two sex groups. At the same time, contrary to the 24-hour experiment, increased
p53
gene expression levels could be seen in several tissues in both sex groups. In order to get a better understanding of the effects of MBB on the DMBA-induced gene expressions "long-term" and "follow-up" studies should be performed.
...
PMID:Effect of E-2-(4'-methoxybenzylidene)-1-benzosuberone on the 7,12-dimethylbenz[alpha]anthracene-induced onco/suppressor gene action in vivo II: A 48-hour experiment. 1092 16
Collaborator of alternative reading frame protein (CARF) associates directly with ARF,
p53
, and/or human double minute 2 protein (HDM2), a ubiquitin-protein ligase, without cofactors and regulates cell proliferation by forming a negative feedback loop. Although ARF,
p53
, and HDM2 also participate in the regulation of ribosome biogenesis, the involvement of CARF in this process remains unexplored. In this study, we demonstrate that CARF associates with 5'-3' exoribonuclease 2 (XRN2), which plays a major role in both the maturation of rRNA and the degradation of a variety of discarded pre-rRNA species. We show that overexpression of CARF increases the localization of XRN2 in the nucleoplasm and a concomitant suppression of pre-rRNA processing that leads to accumulation of the 5' extended from of 45S/47S pre-rRNA and 5'-01, A0-1 and
E-2
fragments of pre-rRNA transcript in the nucleolus. This was also observed upon XRN2 knockdown. Knockdown of CARF increased the amount of XRN2 in the nucleolar fraction as determined by cell fractionation and by immnocytochemical analysis. These observations suggest that CARF regulates early steps of pre-rRNA processing during ribosome biogenesis by controlling spatial distribution of XRN2 between the nucleoplasm and nucleolus.
...
PMID:Collaborator of alternative reading frame protein (CARF) regulates early processing of pre-ribosomal RNA by retaining XRN2 (5'-3' exoribonuclease) in the nucleoplasm. 2653 22